Search
Displaying 521–530 of 532 for “Retinitis pigmentosa”
-
The Foundation Fighting Blindness and Dr. H. James & Carole Free Collaborate to Combat AMD
Foundation NewsAge-related macular degeneration (AMD) is the leading cause of blindness for people over 50 years of age in developed countries.
-
Clinical Trials that are open now
-
Foundation News
The Foundation Fighting Blindness (FFB), the world’s leading private funding source for inherited retinal disease research, announced major awards in two areas: promising research projects in retinal diseases and career development for clinical researchers.
-
Forty High-Impact Retinal-Research Efforts Highlighted at FFB-Casey Innovation Summit
Research NewsIn its fifth year, the Innovation Summit featured 40 presentations from industry experts from around the world.
-
Foundation Fighting Blindness Urges Congress to Pass ‘Eye-Bonds’ Legislation
Foundation NewsBill Introduced in U.S. House Would Speed Up Cures for Blindness
-
The Foundation Fighting Blindness Presents the Emerging Science Showcase at OIS Retina 2018
Foundation NewsFour research and development leaders share the latest details of their groundbreaking work in therapies for retinal degenerative diseases.
-
Foundation News
Dr. Kelley brings more than 25 years of experience in developing, identifying, and advancing life science technologies to this leadership role at FFB
-
Foundation News
The primary goal of the landmark study, funded by the Foundation, is to provide companies and researchers with disease-progression data and potential clinical trial endpoints to drive therapy development
-
Foundation Fighting Blindness Announces Leadership Succession Plan After 45 Year Legacy
Foundation NewsDavid Brint has been elected Chairman, effective July 1, 2016. Brint succeeds co-founder and current Chairman, Gordon Gund, who will remain a member of the Board of Directors and will continue to be actively involved in the Foundation’s Research Oversight Committee
-
The Challenge Continues: FFB Chairman Gordon Gund is Interviewed on CNBC
In the PressIn a recent interview with CNBC’ s Brian Sullivan, during a tech-investor conference in Nantucket, Gordon explained why this is such a crucial time in retinal-research history.
